Diagnosis as a guide to stroke therapy

Lancet

Volumn 352, Issue SUPPL.3, 1998, Pages 5-9

  Vuadens, Philippe ^a   Bogousslavsky, Julien ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; TISSUE PLASMINOGEN ACTIVATOR;

ANGIOGRAPHY; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; HUMAN; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; STROKE;

EID: 0032564240     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0140-6736(98)90087-3     Document Type: Article

References (32)

1. Kothari R, Sauerbeck L, Jauch E, et al. Patient's awareness of stroke signs, symptoms, and risk factors. Stroke 1997; 28: 1871-75.
2. Ferro JM, Falcao I, Rodrigues G, et al. Diagnosis of transient ischemic attack by the nonneurologist: a validation study. Stroke 1996; 27: 2225-29.
3. Aboderin I, Venables G, for the Pan European Consensus Meeting on Stroke Management. Stroke Management in Europe. J Intern Med 1996; 240: 173-80.
4. Adams HP, Brott TG, Crowell RM, et al. Guidelines for the management of patients with acute ischemic stroke: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1994; 25: 1901-14.
5. Bogousslavsky J, Brott T, Diener HC, et al. The European Ad Hoc Consensus Group. European strategies for early intervention in stroke: a report of an Ad Hoc Consensus Group Meeting. Cerebrovasc Dis 1996; 6: 315-24.
6. Adams HP, Brott TG, Furlan AJ, et al. Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1996; 27: 1711-18.
7. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-87.
8. Hacke W, Kaste M, Fieschi C, et al, for the ECASS Study Group. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995; 274: 1017-25.
9. Kaste M, Palomaki H, Sarna S. Where and how should elderly stroke patients be treated? Stroke 1995; 26: 249-53.
10. Bogousslavsky J. Topographic pattern of cerebral infarcts. Cerebrovasc Dis 1991; 1 (suppl): 61-68.
11. Ghika JA, Bogousslavsky J, Regli F. Deep perforators from carotid system. Arch Neurol 1990; 47: 1097-100.
12. Bamford JM. The classification and natural history of acute cerebrovascular disease. In: Wade DT, eds. Measurement in neurological rehabilitation. Oxford: Oxford University Press, 1996: 303-04.
13. Besson G, Robert C, Hommel M, Perret J. Is it clinically possible to distinguish non haemorrhagic infarct from haemorrhagic stroke? Stroke 1995; 26: 1205-09.
14. Brott T, Adams HP, Olinger CP, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989; 20: 864-70.
15. Orgogozo JM, Asplund K, Boysen G. A unified form for neurological scoring of hemispheric stroke. Stroke 1992; 23: 1678-79.
16. Edwards DR, Chen YW, Diringer MN. Unified Neurological Stroke Scale is valid in ischemic and haemorrhagic stroke. Stroke 1995; 26: 1852-58.
17. Teasdale G, Jennett B. Assessment of coma and impaired consciousness: a practical scale. Lancet 1974; ii: 81-83.
18. Von Kummer R, Bozzao L, Manelfe C. Early CT diagnosis of hemispheric brain infarction. Berlin: Springer-Verlag, 1995.
19. Leys D, Pruvo JP, Godefroy O, Rondepierre P, Leclerc X. Prevalence and significance of hyperdense middle cerebral artery in acute stroke. Stroke 1992; 23: 317-24.
20. Von Kummer R, Bozzao L, Bastianello S, Manelfe C, for the ECASS Group. Extent of ischemic brain edema and the response to plasminogen activator in acute ischemic hemispheric stroke. Stroke 1997; 28: 270.
21. The NINDS t-PA Stroke Study Group. Intracerebral haemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke 1997; 28: 2109-18.
22. Damasio H. A computed tomographic guide to the identification of cerebral vascular territories. Arch Neurol 1983; 40: 138-42.
23. Fisher M, Prichard JW, Warrach S. New magnetic resonance techniques for acute ischemic stroke. JAMA 1995; 274: 908-11.
24. Rosen BR, Belliveau JW, Chien D. Perfusion imaging by nuclear magnetic resonance. Magn Reson Q 1989; 5: 263-81.
25. Warrach S, Dashe JF, Edelman RR. Clinical outcome in ischemic stroke predicted by early diffusion-weighted and perfusion magnetic resonance imaging. J Cereb Blood Flow Metab 1996; 16: 53-59.
26. Worthy SA, Henderson J, Griffiths PD, Oates CP, Gholkar A. The role of duplex sonography and angiography in the investigation of carotid artery disease. Neuroradiology 1997; 39: 122-26.
27. De Bray JN, Glatt B. Quantification of atheromatous stenosis in the extracranial internal carotid artery. Cerebrovasc Dis 1995; 5: 414.
28. Vanninen RI, Manninen HI, Partanen PK, Tulla H, Vainio PA. How should we estimate carotid stenosis using magnetic resonance angiography. Stroke 1993; 24: 1310-15.
29. Röther J, Wentz K, Schwartz A, Rutenberg W, Hennerici M. Magnetic resonance angiography of vertebrobasilar ischemia. Stroke 1993; 24: 1310-15.
30. Röther J, Schwartz A, Rautenberg W, Hennerici M. MR-angiography of Doppler sonographically suspected vertebral artery dissection. J Neurol 1995; 242: 430-36.
31. Siewert B, Wielopolski PA, Schlaug G, Edelman RR, Warach S. STAR MR angiography for rapid detection of vascular abnormalities in patients with acute cerebrovascular disease. Stroke 1997; 28: 1211-15.
32. Nendaz M, Sarasin FP, Bogousslavsky J. How to prevent stroke recurrence in patients with patent foramen ovale: anticoagulants, antiaggregants, foramen closure, or nothing? Eur Neurol 1997; 37: 199-204.